StockNews.com assumed coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reiterated an overweight rating on shares of Zynerba Pharmaceuticals in a research note on Friday, March 31st. One research analyst has rated […]
StockNews.com initiated coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the stock. Zynerba Pharmaceuticals Trading Down 6.8 % Shares of NASDAQ:ZYNE opened at $0.40 on Tuesday. The company has a 50 day moving average of $0.51 […]
Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) is scheduled to announce its earnings results on Friday, March 24th. Zynerba Pharmaceuticals Trading Down 3.2 % Shares of Zynerba Pharmaceuticals stock traded down $0.02 on Thursday, reaching $0.46. 160,447 shares of the company were exchanged, compared to its average volume of 330,585. The company has a market capitalization […]